delete National Health Act 1953 (Amendment) Regulations
Amendment regulations to the National Health Act 1953, which governs Australia's national health system including Medicare and the Pharmaceutical Benefits Scheme (PBS). Without access to the specific 2005 amendments, the parent Act establishes centralized price controls on pharmaceuticals, government-funded health subsidies, and regulatory oversight of health service providers and pharmaceutical manufacturers.
The National Health Act 1953 and its amendments embody the fundamental problem of centralized price fixing and subsidy regimes in healthcare. The PBS alone has resulted in drug shortages, delayed listings, and distorted pharmaceutical markets where Australians pay among the highest prices in the world for medicines. Government intervention in health markets, however well-intentioned, creates unintended consequences including reduced supply, innovation stifled by price controls, and resource misallocation. The 2005 amendments would perpetuate or expand these distortions. From a Mises/Hayek/Friedman framework, healthcare markets function best when competition and private property rights operate freely, not under regulatory command. The PBS model of government-negotiated prices is unsustainable and represents a cost burden on Australians through both taxation and reduced access to innovative medicines that would otherwise reach the market faster in a competitive environment.